Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of AVAI BIO, INC. from 31 Mar 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary: AVAI BIO, INC. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 31 Mar 2019 to 31 Dec 2024.
AVAI BIO, INC. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 31 Dec 2024 was $452,298, a 55% increase year-over-year.
Source SEC data: View on sec.gov

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)

AVAI BIO, INC. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$452,298	+$561,602	+55%	01 Oct 2024	31 Dec 2024	10-Q	07 Feb 2025	2025	Q3
Q3 2024	$623,046	-$223,425	-56%	01 Jul 2024	30 Sep 2024	10-Q/A	21 Jan 2025	2025	Q2
Q2 2024	$528,843	-$117,321	-29%	01 Apr 2024	30 Jun 2024	10-Q/A	21 Jan 2025	2025	Q1
Q4 2023	$1,013,900			01 Oct 2023	31 Dec 2023	10-Q	07 Feb 2025	2025	Q3
Q3 2023	$399,621			01 Jul 2023	30 Sep 2023	10-Q/A	21 Jan 2025	2025	Q2
Q2 2023	$411,522			01 Apr 2023	30 Jun 2023	10-Q/A	21 Jan 2025	2025	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2018	$78,225			01 Apr 2018	31 Mar 2019	10-K	15 Jul 2019	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.